Literature DB >> 27022656

The loss of MiR-139-5p promotes colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt signaling.

Rurong Maoa, Fangyuan Zou, Liyan Yang, Shengchao Lin, Yueqi Li, Mingxing Ma, Peihao Yin, Xin Liang, Jianwen Liu.   

Abstract

MiR-139-5p down-regulation has frequently been implicated in colorectal carcinoma. However, there is little known about its biological function between inflammation and cancer in vivo. Here, a transgenic murine model of colorectal carcinoma was used to investigate pathogenetic role of miR-139-5p in colitis and colitis-associated tumorigenesis. We showed that miR-139-5p knockout mice were higher sensitive to DSS-induced colitis and enhanced formation of intestinal neoplasia was observed when mice were exposed to AOM/DSS treatment. MiR-139-5p knockout mice exhibited an increased expression of genes involved in Wnt pathway. Such genes are closely associated with cell proliferation and differentiation, promoting the β-catenin nuclear accumulation. Furthermore, biochemical studies in HCT-116 cells revealed that the over-expression of miR-139-5p inhibited the crosstalk between PI3K/AKT and Wnt pathway mediated by IGF-1R. Collectively, these findings indicate that miR-139-5p plays a crucial role in the development and progression of colitis-associated tumorigenesis and suggest that miR-139-5p may serve as a potential therapeutic target for the treatment of colitis-associated cancer in the future.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 27022656     DOI: 10.1016/j.biocel.2015.10.008

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  12 in total

1.  Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis.

Authors:  Zhengqiang Wang; Qianshan Ding; Yanxia Li; Qingqing Liu; Wei Wu; Lu Wu; Honggang Yu
Journal:  Tumour Biol       Date:  2016-09-16

2.  Hyperthermic intraperitoneal chemotherapy with recombinant mutant human TNF-α and raltitrexed in mice with colorectal-peritoneal carcinomatosis.

Authors:  Qianyi Gong; Changfeng Song; Xiaotong Wang; Renjie Wang; Guoxiang Cai; Xin Liang; Jianwen Liu
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-10

3.  Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes.

Authors:  Yury O Nunez Lopez; Berta Victoria; Pawel Golusinski; Wojciech Golusinski; Michal M Masternak
Journal:  Rep Pract Oncol Radiother       Date:  2017-11-20

4.  Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells.

Authors:  Xin Liang; Haiyang Shi; Liyan Yang; Cen Qiu; Shengchao Lin; Yingxue Qi; Jiyu Li; Aiguang Zhao; Jianwen Liu
Journal:  Br J Cancer       Date:  2017-02-21       Impact factor: 7.640

5.  miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targetting c-Jun.

Authors:  Su Ming; Wang Shui-Yun; Qiu Wei; Li Jian-Hui; Hui Ru-Tai; Song Lei; Jia Mei; Wang Hui; Wang Ji-Zheng
Journal:  Biosci Rep       Date:  2018-03-09       Impact factor: 3.840

6.  MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.

Authors:  Fengling Li; Aihua Liang; Yan Lv; Guohong Liu; Aili Jiang; Peishu Liu
Journal:  Med Sci Monit       Date:  2017-10-28

7.  Targeting miR-223 in neutrophils enhances the clearance of Staphylococcus aureus in infected wounds.

Authors:  Maiko de Kerckhove; Katsuya Tanaka; Takahiro Umehara; Momoko Okamoto; Sotaro Kanematsu; Hiroko Hayashi; Hiroki Yano; Soushi Nishiura; Shiho Tooyama; Yutaka Matsubayashi; Toshimitsu Komatsu; Seongjoon Park; Yuka Okada; Rina Takahashi; Yayoi Kawano; Takehisa Hanawa; Keisuke Iwasaki; Tadashige Nozaki; Hidetaka Torigoe; Kazuya Ikematsu; Yutaka Suzuki; Katsumi Tanaka; Paul Martin; Isao Shimokawa; Ryoichi Mori
Journal:  EMBO Mol Med       Date:  2018-10       Impact factor: 12.137

8.  MicroRNA-139-5p regulates chronic inflammation by suppressing nuclear factor-κB activity to inhibit cell proliferation and invasion in colorectal cancer.

Authors:  Mingming Zhu; Wen Zhang; Jun Ma; Youguo Dai; Qi Zhang; Qin Liu; Burong Yang; Gang Li
Journal:  Exp Ther Med       Date:  2019-09-20       Impact factor: 2.447

9.  Ginsenoside Rg3 protects against iE-DAP-induced endothelial-to-mesenchymal transition by regulating the miR-139-5p-NF-κB axis.

Authors:  Aram Lee; Eunsik Yun; Woochul Chang; Jongmin Kim
Journal:  J Ginseng Res       Date:  2019-01-21       Impact factor: 6.060

10.  miR‑139‑5p affects cell proliferation, migration and adipogenesis by targeting insulin‑like growth factor 1 receptor in hemangioma stem cells.

Authors:  Yao Wu; Honghong Li; Juan Xie; Fan Wang; Dongsheng Cao; Yin Lou
Journal:  Int J Mol Med       Date:  2019-12-17       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.